Sedation and analgesia in post-cardiac arrest care: a post hoc analysis of the TTM2 trial
Language English Country Great Britain, England Media electronic
Document type Journal Article, Randomized Controlled Trial
PubMed
40528173
PubMed Central
PMC12175406
DOI
10.1186/s13054-025-05461-0
PII: 10.1186/s13054-025-05461-0
Knihovny.cz E-resources
- Keywords
- Cardiac arrest, Midazolam, Propofol, Sedation, Seizures, Targeted temperature management,
- MeSH
- Analgesics therapeutic use MeSH
- Analgesia * methods standards statistics & numerical data MeSH
- Deep Sedation methods standards MeSH
- Hypnotics and Sedatives therapeutic use MeSH
- Middle Aged MeSH
- Humans MeSH
- Logistic Models MeSH
- Propofol therapeutic use MeSH
- Aged MeSH
- Out-of-Hospital Cardiac Arrest * therapy MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Randomized Controlled Trial MeSH
- Names of Substances
- Analgesics MeSH
- Hypnotics and Sedatives MeSH
- Propofol MeSH
BACKGROUND: The routine use of sedation and analgesia during post-cardiac arrest care and its association with clinical outcomes remain unclear. This study aimed to describe the use of sedatives and analgesics in post-cardiac arrest care, and evaluate associations with good functional outcome, survival, clinical seizures, and late awakening. METHODS: This was a post hoc analysis of the TTM2-trial, which randomized 1900 out-of-hospital cardiac arrest patients to either normothermia or hypothermia. In both groups, deep sedation (Richmond Agitation and Sedation Scale ≤ -4) was mandatory during the 40-h intervention. Cumulative doses of sedatives and analgesic drugs were recorded within the first 72 h from randomization. Outcomes were functional outcome (modified Rankin Scale) and survival status at 6 months, occurrence of clinical seizures during the intensive care stay, and late awakening (Full outline of unresponsiveness motor score of four 96 h after randomization). Cumulative propofol doses were divided into quartiles (Q1-Q4). Logistic regression models were used to assess associations between sedative doses and functional outcome and survival, clinical seizures, and late awakening, adjusting for the severity of illness and other clinical factors influencing sedation. RESULTS: A total of 1861 patients were analyzed. In a multivariable logistic regression model, higher propofol doses (Q3, 100.7-153.6 mg/kg) were associated with good functional outcome (OR 1.62, 95%CI 1.12-2.34) and (Q2 and Q3, 43.9-153.6 mg/kg) with survival (OR 1.49, 95%CI 1.05-2.12 and OR 1.84, 95%CI 1.27-2.65, respectively). Receiving fentanyl and remifentanil were associated with good functional outcome (OR 1.69, 95%CI 1.27-2.26 and OR 1.50, 95%CI 1.11-2.02) and survival (OR 1.80, 95%CI 1.35-2.40 and OR 1.56, 95%CI 1.16-2.10). Receiving fentanyl (OR 0.64, 95%CI 0.48-0.86) and higher propofol doses (Q2-4 (43.9-669.4 mg/kg) were associated with the occurrence of clinical seizures. The highest quartile of propofol dose (153.7-669.4 mg/kg, OR 3.19, 95%CI 1.91-5.42) was associated with late awakening. CONCLUSIONS: In this study, higher doses of propofol and the use of remifentanil and fentanyl were associated with good functional outcome and survival, occurrence of clinical seizures, and late awakening.
Adult Critical Care University Hospital of Wales Cardiff UK
Cardiology Department Lund University Skåne University Hospital Lund Lund Sweden
Department of Clinical Medicine Aarhus University Aarhus N Denmark
Department of Clinical Sciences Lund Neurology and Rehabilitation Lund University Lund Sweden
Department of Critical Care Maine Medical Center Portland ME USA
Department of Intensive Care Medicine Aarhus University Hospital Aarhus N Denmark
Department of Intensive Care Medicine University Hospital Bern University of Bern Bern Switzerland
Department of Intensive Care University Hospitals Bristol and Weston Bristol UK
Institute of Heart Diseases Wroclaw Medical University Wroclaw Poland
Intensive Care Department Kantonsspital St Gallen St Gallen Switzerland
Medical ICU Cochin University Hospital AP HP Centre Université Paris Cité Paris France
Neurology Department of Clinical Sciences Lund Lund University Skåne University Hospital Lund Sweden
Neurology Department of Clinical Sciences Lund University Lund Sweden
The Australian and New Zealand Intensive Care Research Centre Monash University Melbourne Australia
See more in PubMed
Thomassen AWM. Prevalence and prognostic significance of coma after cardiac arrest outside intensive care and coronary units. Acta Anaesthesiol Scand. 1979;23(2):143–8. PubMed
Dragancea I, Horn J, Kuiper M, et al. Neurological prognostication after cardiac arrest and targeted temperature management 33 degrees C versus 36 degrees C: Results from a randomised controlled clinical trial. Resuscitation. 2015;93:164–70. PubMed
Sandroni C, Nolan JP, Andersen LW, et al. ERC-ESICM guidelines on temperature control after cardiac arrest in adults. Intensive Care Med. 2022;48(3):261–9. PubMed
Nolan JPSC, Bottiger BW, et al. European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2021: post-resuscitation care. Intensive Care Med. 2021;47(4):369–421. PubMed PMC
Hirsch KG, Abella BS, Amorim E, et al. Critical Care Management of Patients After Cardiac Arrest: A Scientific Statement From the American Heart Association and Neurocritical Care Society. Circulation. 2024;149(2):e168–200. PubMed PMC
Nielsen NHJ, Nilsson F. Outcome, timing and adverse events in therapeutic hypothermia after out-of-hospital cardiac arrest. Acta Anaesthesiol Scand. 2009;53:926–34. PubMed
Rossetti AO, Tovar Quiroga DF, Juan E, et al. Electroencephalography Predicts Poor and Good Outcomes After Cardiac Arrest: A Two-Center Study. Crit Care Med. 2017;45(7):e674–82. PubMed
Oddo M, Crippa IA, Mehta S, et al. Optimizing sedation in patients with acute brain injury. Crit Care. 2016;20(1):128. PubMed PMC
Dunn LK, Naik BI, Nemergut EC, Durieux ME. Post-Craniotomy Pain Management: Beyond Opioids. Curr Neurol Neurosci Rep. 2016;16(10):93. PubMed
Treggiari MM, Romand JA, Yanez ND, et al. Randomized trial of light versus deep sedation on mental health after critical illness. Crit Care Med. 2009;37(9):2527–34. PubMed
Kress JPPA, O’Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000;342(20):1471–7. PubMed
Shehabi Y, Chan L, Kadiman S, et al. Sedation depth and long-term mortality in mechanically ventilated critically ill adults: a prospective longitudinal multicentre cohort study. Intensive Care Med. 2013;39(5):910–8. PubMed PMC
SRLF Trial Group. Impact of oversedation prevention in ventilated critically ill patients: a randomized trial-the AWARE study. Ann Intensive Care. 2018;8(1):93. PubMed PMC
Dale Craig M, et al. Understanding early decisions to withdraw life-sustaining therapy in cardiac arrest survivors a qualitative investigation. Annals Am Thorac Soc. 2016;13(7):1115–22. PubMed
Mulder MGH, Smith SW, Dhaliwal R, Scott NL, Sprenkle MD, Geocadin RG. Awakening and withdrawal of life-sustaining treatment in cardiac arrest survivors treated with therapeutic hypothermia*. Crit Care Med. 2014;42(12):2493–9. PubMed PMC
von Elm EAD, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453–7. PubMed
Dankiewicz JCT, Lilja G, Jakobsen JC, Levin H, Ullén S, Rylander C, Wise MP, Oddo M, Cariou A, Bělohlávek J, Hovdenes J, Saxena M, Kirkegaard H, Young PJ, Pelosi P, Storm C, Taccone FS, Joannidis M, Callaway C, Eastwood GM, Morgan MPG, Nordberg P, Erlinge D, Nichol AD, Chew MS, Hollenberg J, Thomas M, Bewley J, Sweet K, Grejs AM, Christensen S, Haenggi M, Levis A, Lundin A, Düring J, Schmidbauer S, Keeble TR, Karamasis GV, Schrag C, Faessler E, Smid O, Otáhal M, Maggiorini M, Wendel Garcia PD, Jaubert P, Cole JM, Solar M, Borgquist O, Leithner C, Abed-Maillard S, Navarra L, Annborn M, Undén J, Brunetti I, Awad A, McGuigan P, Bjørkholt Olsen R, Cassina T, Vignon P, Langeland H, Lange T, Friberg H, Nielsen N. TTM2 Trial investigators: hypothermia versus normothermia after out-of-hospital cardiac arrest. N Engl J Med. 2021;384(24):2283–94. PubMed
Dankiewicz JCT, Lilja G, Jakobsen JC, Bělohlávek J, Callaway C, Cariou A, Eastwood G, Erlinge D, Hovdenes J, Joannidis M, Kirkegaard H, Kuiper M, Levin H, Morgan MPG, Nichol AD, Nordberg P, Oddo M, Pelosi P, Rylander C, Saxena M, Storm C, Taccone F, Ullén S, Wise MP, Young P, Friberg H, Nielsen N. Targeted hypothermia versus targeted Normothermia after out-of-hospital cardiac arrest (TTM2): A randomized clinical trial-Rationale and design. Am Heart J. 2019;217:23–31. PubMed
Sessler CN, Gosnell MS, Grap MJ, et al. The richmond agitation-sedation scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166(10):1338–44. PubMed
Badjatia N, Strongilis E, Gordon E, et al. Metabolic impact of shivering during therapeutic temperature modulation: the Bedside Shivering Assessment Scale. Stroke. 2008;39(12):3242–7. PubMed
Van Swieten JC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604–7. PubMed
Wijdicks EF, Bamlet WR, Maramattom BV, Manno EM, McClelland RL. Validation of a new coma scale: the FOUR score. Ann Neurol. 2005;58(4):585–93. PubMed
Rossetti AOOM, Logroscino G, Kaplan PW. Prognostication after cardiac arrest and hypothermia: a prospective study. Ann Neurol. 2010;67:301–7. PubMed
Bouwes Aline, et al. Acute posthypoxic myoclonus after cardiopulmonary resuscitation. BMC neurology. 2012;12:1–6. PubMed PMC
Seder DBSK, Rubertsson S. Neurologic outcomes and postresuscitation care of patients with myoclonus following cardiac arrest. Crit Care Med. 2015. 10.1097/SA.0000000000000181. PubMed
Elmer JRJ, Faro J. Clinically distinct electroencephalographic phenotypes of early myoclonus after cardiac arrest. Ann Neurol. 2016;80:175–84. PubMed PMC
Backman SWE, Dragancea I, Friberg H, Rundgren M, Ullen S. Cronberg T Electroencephalographic characteristics of status epilepticus after cardiac arrest. Clin Neurophysiol Off J Int Fed Clin Neurophysiol. 2017;128:681–8. PubMed
Lee DH, Lee BK, Cho YS, et al. High heat generation is associated with good neurologic outcome in out-of-hospital cardiac arrest survivors underwent targeted temperature management at 33 degrees C. Resuscitation. 2020;153:187–94. PubMed
Nair SU, Lundbye JB. The occurrence of shivering in cardiac arrest survivors undergoing therapeutic hypothermia is associated with a good neurologic outcome. Resuscitation. 2013;84(5):626–9. PubMed
Hovdenes J, Roysland K, Nielsen N, et al. A low body temperature on arrival at hospital following out-of-hospital-cardiac-arrest is associated with increased mortality in the TTM-study. Resuscitation. 2016;107:102–6. PubMed
Lee DH, Lee BK, Cho YS, et al. High heat generation is associated with good neurologic outcome in out-of-hospital cardiac arrest survivors underwent targeted temperature management at 33 °C. Resuscitation. 2020;153:187–94. PubMed
May TL, Riker RR, Fraser GL, et al. Variation in sedation and neuromuscular blockade regimens on outcome after cardiac arrest. Crit Care Med. 2018;46(10):e975–80. PubMed PMC
Geller BJ, Maciel CB, May TL, Jentzer JC. Sedation and shivering management after cardiac arrest. Eur Heart J Acute Cardiovasc Care. 2023;12(8):518–24. PubMed
Bjelland TW, Dale O, Kaisen K, et al. Propofol and remifentanil versus midazolam and fentanyl for sedation during therapeutic hypothermia after cardiac arrest: a randomised trial. Intensive Care Med. 2012;38(6):959–67. PubMed
Paul M, Bougouin W, Dumas F, et al. Comparison of two sedation regimens during targeted temperature management after cardiac arrest. Resuscitation. 2018;128:204–10. PubMed
Lybeck A, Cronberg T, Aneman A, et al. Time to awakening after cardiac arrest and the association with target temperature management. Resuscitation. 2018;126:166–71. PubMed
van den Broek MPGF, Egberts AC, Rademaker CM. Effects of hypothermia on pharmacokinetics and pharmacodynamics: a systematic review of preclinical and clinical studies. Clin Pharmacokinet. 2010;49(5):277–94. PubMed
Leslie KSD, Bjorksten AR, Moayeri A. Mild hypothermia alters propofol pharmacokinetics and increases the duration of action of atracurium. Anesth Analg. 1995;80(5):1007–14. PubMed
Tortorici MA, Kochanek PM, Poloyac SM. Effects of hypothermia on drug disposition, metabolism, and response: a focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system. Crit Care Med. 2007;35(9):2196–204. PubMed
Varghese JM, Roberts JA, Lipman J. Pharmacokinetics and pharmacodynamics in critically ill patients. Curr Opin Anaesthesiol. 2010;23(4):472–8. PubMed
Celis-Rodríguez E, Díaz Cortés JC, Cárdenas Bolívar YR, et al. Evidence-based clinical practice guidelines for the management of sedoanalgesia and delirium in critically ill adult patients. Med Intensiva (Engl Ed). 2020;44(3):171–84. PubMed
DAS-Taskforce 2015; Baron R, Binder A, Biniek R PubMed PMC
Devlin JW, Skrobik Y, Gelinas C, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46(9):e825–73. PubMed
Gonzalez D, Dahiya G, Mutirangura P, et al. Post cardiac arrest care in the cardiac intensive care unit. Curr Cardiol Rep. 2024;26(2):35–49. PubMed
Orban JC, Cattet F, Lefrant JY, et al. The practice of therapeutic hypothermia after cardiac arrest in France: a national survey. PLoS ONE. 2012;7(9): e45284. PubMed PMC
Deye N, Cariou A, Girardie P, et al. Endovascular versus external targeted temperature management for patients with out-of-hospital cardiac arrest: a randomized. Control Study Circ. 2015;132(3):182–93. PubMed
Kamps MJ, Horn J, Oddo M, et al. Prognostication of neurologic outcome in cardiac arrest patients after mild therapeutic hypothermia: a meta-analysis of the current literature. Intensive Care Med. 2013;39(10):1671–82. PubMed
Ceric A, May TL, Lybeck A, et al. Cardiac arrest treatment center differences in sedation and analgesia dosing during targeted temperature management. Neurocrit Care. 2023;38(1):16–25. PubMed PMC
Dolmans RGF, Nahed BV, Robertson FC, Peul WC, Rosenthal ES, Broekman MLD. Practice-pattern variation in sedation of neurotrauma patients in the intensive care unit: an international survey. J Intensive Care Med. 2023;38(12):1143–50. PubMed PMC